59 related articles for article (PubMed ID: 3192620)
1. Tumor necrosis factor inhibits the terminal event in mesenchymal stem cell differentiation.
Filipak M; Sparks RL; Tzen CY; Scott RE
J Cell Physiol; 1988 Nov; 137(2):367-73. PubMed ID: 3192620
[TBL] [Abstract][Full Text] [Related]
2. Loss of differentiation control in transformed 3T3 T proadipocytes.
Sparks RL; Allen BJ; Zygmunt AI; Strauss EE
Cancer Res; 1993 Apr; 53(8):1770-6. PubMed ID: 8467495
[TBL] [Abstract][Full Text] [Related]
3. Defective control of terminal differentiation and its role in carcinogenesis in the 3T3 T proadipocyte stem cell line.
Wier ML; Scott RE
Cancer Res; 1985 Jul; 45(7):3339-46. PubMed ID: 4005857
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
5. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
Ferret-Bernard S; Saï P; Bach JM
Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
[TBL] [Abstract][Full Text] [Related]
6. Differentiation, dedifferentiation, and transdifferentiation of BALB/c 3T3 T mesenchymal stem cells: potential significance in metaplasia and neoplasia.
Sparks RL; Seibel-Ross EI; Wier ML; Scott RE
Cancer Res; 1986 Oct; 46(10):5312-9. PubMed ID: 3756880
[TBL] [Abstract][Full Text] [Related]
7. Polypeptide changes associated with loss of proliferative potential during the terminal event in differentiation.
Wier ML; Scott RE
J Cell Biochem; 1987 Feb; 33(2):137-50. PubMed ID: 2437134
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of p55 and p75 tumor necrosis factor receptors.
Rusten LS; Smeland EB; Jacobsen FW; Lien E; Lesslauer W; Loetscher H; Dubois CM; Jacobsen SE
J Clin Invest; 1994 Jul; 94(1):165-72. PubMed ID: 7518828
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha modulates survival, proliferation, and neuronal differentiation in neonatal subventricular zone cell cultures.
Bernardino L; Agasse F; Silva B; Ferreira R; Grade S; Malva JO
Stem Cells; 2008 Sep; 26(9):2361-71. PubMed ID: 18583543
[TBL] [Abstract][Full Text] [Related]
10. The antiangiogenic agent linomide inhibits tumor necrosis factor-alpha secretion via inhibition of its synthesis.
Joseph IB; Isaacs JT
Prostate; 1996 Sep; 29(3):183-90. PubMed ID: 8827087
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
Chen J; Jacobs-Helber SM; Barber DL; Sawyer ST
Exp Cell Res; 2004 Aug; 298(1):155-66. PubMed ID: 15242770
[TBL] [Abstract][Full Text] [Related]
12. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of stem cell factor-induced proliferation of primitive murine hematopoietic progenitor cells signaled through the 75-kilodalton tumor necrosis factor receptor. Regulation of c-kit and p53 expression.
Jacobsen FW; Dubois CM; Rusten LS; Veiby OP; Jacobsen SE
J Immunol; 1995 Apr; 154(8):3732-41. PubMed ID: 7535812
[TBL] [Abstract][Full Text] [Related]
14. Authentic 17 kDa tumour necrosis factor alpha is synthesized and released by canine mast cells and up-regulated by stem cell factor.
Thomas PS; Pennington DW; Schreck RE; Levine TM; Lazarus SC
Clin Exp Allergy; 1996 Jun; 26(6):710-8. PubMed ID: 8809429
[TBL] [Abstract][Full Text] [Related]
15. IL-6, LIF, and TNF-alpha regulation of GM-CSF inhibition of osteoclastogenesis in vitro.
Gorny G; Shaw A; Oursler MJ
Exp Cell Res; 2004 Mar; 294(1):149-58. PubMed ID: 14980510
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha inhibits epithelial differentiation and morphogenesis in the mouse metanephric kidney in vitro.
Cale CM; Klein NJ; Morgan G; Woolf AS
Int J Dev Biol; 1998 Jul; 42(5):663-74. PubMed ID: 9712521
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha stimulates cell proliferation in adipose tissue-derived stromal-vascular cell culture: promotion of adipose tissue expansion by paracrine growth factors.
Kras KM; Hausman DB; Martin RJ
Obes Res; 2000 Mar; 8(2):186-93. PubMed ID: 10757205
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
19. The role of noggin in human mesenchymal stem cell differentiation.
Rifas L
J Cell Biochem; 2007 Mar; 100(4):824-34. PubMed ID: 17133353
[TBL] [Abstract][Full Text] [Related]
20. Aproliferin: a modulator of proliferative potential.
Wier ML; Scott RE
Biofactors; 1988 Jul; 1(2):129-31. PubMed ID: 3076440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
